<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/acrv" ></link>
<id>urn:uuid:4164105d-f4b6-e2cc-7abb-c41531562a89</id>
<updated>2026-09-18T14:42:45-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ACRV: LEVIN MICHAELA (O) Acquired (JB) 30k Shares of ACRIVON THERAPEUTICS INC for $0.00 on 8/31</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6463564" ></link>
<id>urn:uuid:94c14012-99c5-ae0d-4355-ebb004cfde66</id>
<updated>2026-09-02T16:30:31-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: LEVIN MICHAELA (O) Filed a Form 3, Becoming a Registered Insider at ACRIVON THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6463491" ></link>
<id>urn:uuid:a37159dd-0ba4-b8cc-6100-f39b7784ebdf</id>
<updated>2026-09-02T16:26:32-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Sold (S) 14,036 Shares of ACRIVON THERAPEUTICS INC for $2.21 on 8/25</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6461095" ></link>
<id>urn:uuid:3975d870-60a1-8f47-2436-4a35065fb3b0</id>
<updated>2026-08-27T16:14:53-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: PETERSON KATHARINE (CAO) Sold (S) 101 Shares of ACRIVON THERAPEUTICS INC for $2.01 on 8/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6457730" ></link>
<id>urn:uuid:733c14f9-9cec-7da0-2019-85e88a1eb357</id>
<updated>2026-08-20T16:10:19-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: MILLER MARY (LO) Sold (S) 185 Shares of ACRIVON THERAPEUTICS INC for $2.01 on 8/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6457739" ></link>
<id>urn:uuid:13e9a253-e38c-1b40-7ba3-36f65996f976</id>
<updated>2026-08-20T16:09:33-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: GAMELIN ERICK (O) Sold (S) 400 Shares of ACRIVON THERAPEUTICS INC for $2.01 on 8/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6457718" ></link>
<id>urn:uuid:285c5fbc-cb98-60ec-1843-234187a83488</id>
<updated>2026-08-20T16:08:39-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: DEVROE ERIC (COO) Sold (S) 604 Shares of ACRIVON THERAPEUTICS INC for $2.01 on 8/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6457721" ></link>
<id>urn:uuid:18e53169-a4b7-5f83-d94f-ea04c43655b8</id>
<updated>2026-08-20T16:07:50-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Sold (S) 484 Shares of ACRIVON THERAPEUTICS INC for $2.01 on 8/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6457714" ></link>
<id>urn:uuid:ef08b0bd-23d2-73ea-f713-c200c0a24267</id>
<updated>2026-08-20T16:07:06-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Sold (S) 1,229 Shares of ACRIVON THERAPEUTICS INC for $2.01 on 8/18</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6457713" ></link>
<id>urn:uuid:ac289fd4-7085-27df-cbf8-a59c2a87841e</id>
<updated>2026-08-20T16:07:06-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
<entry>
<title>ACRV: LEVY ADAM D (CFO) Sold (S) 1,142 Shares of ACRIVON THERAPEUTICS INC for $1.57 on 8/4</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6450111" ></link>
<id>urn:uuid:7d83c323-3793-6303-6acb-7fc97f65aaea</id>
<updated>2026-08-06T16:34:32-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $2.00. Mkt Cap:85.7mm. 10D Vol: 231,880]]></summary>
</entry>
</feed>